BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 31109699)

  • 21. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
    Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
    Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of the whole coding and non-coding RNA transcriptome expression profiles and construction of the circRNA-lncRNA co-regulated ceRNA network in laryngeal squamous cell carcinoma.
    Zhao R; Li FQ; Tian LL; Shang DS; Guo Y; Zhang JR; Liu M
    Funct Integr Genomics; 2019 Jan; 19(1):109-121. PubMed ID: 30128795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary study using a small plasma extracellular vesicle miRNA panel as a potential biomarker for early diagnosis and prognosis in laryngeal cancer.
    Zhang H; Chen Z; Huang Q; Guo Y; Wang M; Wu C
    Cell Oncol (Dordr); 2023 Aug; 46(4):1015-1030. PubMed ID: 36964893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential key molecular correlations in laryngeal squamous cell carcinoma revealed by integrated analysis of mRNA, miRNA and lncRNA microarray profiles.
    Zhang C; Gao W; Wen S; Wu Y; Fu R; Zhao D; Chen X; Wang B
    Neoplasma; 2016; 63(6):888-900. PubMed ID: 27565327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene regulation and prognostic indicators of lung squamous cell carcinoma: TCGA-derived miRNA/mRNA sequencing and DNA methylation data.
    Shen Y; Pan X; Yang J
    J Cell Physiol; 2019 Dec; 234(12):22896-22910. PubMed ID: 31169310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
    Cybula M; Wieteska Ƚ; Józefowicz-Korczyńska M; Karbownik MS; Grzelczyk WL; Szemraj J
    Cancer Biomark; 2016; 16(4):559-68. PubMed ID: 27002759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular RNA Expression Profile in Laryngeal Squamous Cell Carcinoma Revealed by Microarray.
    Fan Y; Xia X; Zhu Y; Diao W; Zhu X; Gao Z; Chen X
    Cell Physiol Biochem; 2018; 50(1):342-352. PubMed ID: 30282067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel insights into laryngeal squamous cell carcinoma from association study of aberrantly expressed miRNAs, lncRNAs and clinical features in Bulgarian patients.
    Garo Kyurkchiyan S; Miroslavov Popov T; Stancheva G; Rangachev J; Ivanov Mitev V; Petrova Popova D; Petrova Kaneva R
    J BUON; 2020; 25(1):357-366. PubMed ID: 32277655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma.
    Wang JL; Wang X; Yang D; Shi WJ
    Yonsei Med J; 2016 Mar; 57(2):298-305. PubMed ID: 26847279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aberrant expressed long non-coding RNAs in laryngeal squamous-cell carcinoma.
    Li H; Wang FL; Li W; Fei YH; Wang YT; Zhang JE; Bi HY; Zhang M
    Am J Otolaryngol; 2019; 40(5):615-625. PubMed ID: 31128861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-330-3p represses the proliferation and invasion of laryngeal squamous cell carcinoma through downregulation of Tra2β-mediated Akt signaling.
    Cheng Y; Zhu H; Gao W
    Mol Cell Probes; 2020 Aug; 52():101574. PubMed ID: 32289378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7.
    Niu JT; Zhang LJ; Huang YW; Li C; Jiang N; Niu YJ
    Biochem Cell Biol; 2018 Dec; 96(6):752-760. PubMed ID: 29874469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
    Zhu M; Zhang C; Chen D; Chen S; Zheng H
    Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive Evaluation of miR-144-3p Expression and Its Targets in Laryngeal Squamous Cell Carcinoma.
    Mo BY; Pang JS; Dai WB; Su YS; Jiang W; Huang SN
    Comput Math Methods Med; 2021; 2021():6684186. PubMed ID: 34326893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low expression of miR-20b-5p indicates favorable prognosis in laryngeal squamous cell carcinoma, especially in patients with non-infiltrated regional lymph nodes.
    Pantazis TL; Giotakis AI; Karamagkiolas S; Giotakis I; Konstantoulakis M; Liakea A; Misiakos EP
    Am J Otolaryngol; 2020; 41(5):102563. PubMed ID: 32521298
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated Analysis of Long Noncoding RNA and mRNA Expression Profile in Advanced Laryngeal Squamous Cell Carcinoma.
    Feng L; Wang R; Lian M; Ma H; He N; Liu H; Wang H; Fang J
    PLoS One; 2016; 11(12):e0169232. PubMed ID: 28033431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
    Sharma P; Saraya A; Sharma R
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.